# MiNK Therapeutics, Inc.: Form 8-K, filed Jul 15, 2025

- Company: [MiNK Therapeutics, Inc.](/companies/inkt.md) (CIK 1840229)
- Form: 8-K
- Filed: 2025-07-15
- Accepted by EDGAR: Jul 15, 2025, 11:05 ET
- Period: 2025-07-15
- Accession: 0001193125-25-159017
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1840229/000119312525159017/d99462d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1840229/000119312525159017/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1840229/000119312525159017/d99462d8k.htm

Filed Jul 15, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-159017. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.